-+ 0.00%
-+ 0.00%
-+ 0.00%

ALUMIS ANNOUNCES NEW PHASE 3 DATA DEMONSTRATING ENVUDEUCITINIB RAPIDLY AND DURABLY IMPROVED PSORIASIS BURDEN ACROSS SCALP, ITCH, AND QUALITY OF LIFE MEASURES

Reuters·10/09/2026 08:01:08